Synthesis of Tetrandrine Derivatives and Their Biological Activity | |
Guo Weifeng2; Xu Jinfang2; Liu Ruiling2; Zhao Zhengbao2; Guo Yuewei1 | |
刊名 | Chinese Journal of Applied Chemistry |
2017 | |
卷号 | 34期号:7页码:789-794 |
关键词 | tetrandrine Suzuki coupling reaction cell counting kit-8 method anti-tumor activity |
ISSN号 | 1000-0518 |
其他题名 | 汉防己甲素衍生物的合成及其生物活性 |
文献子类 | Article |
英文摘要 | In order to explore more effective anti-tumor drugs, and improve the anti-tumor activities of tetrandrine,six new bisbenzylisoquinoline derivatives of tetrandrine were designed and synthesized by Suzuki coupling. The structures of these compounds were confirmed by ~1H nuclear magnetic resonance (~1H NMR), 13C nuclear magnetic resonance(13C NMR), and mass spectrometry (MS). Their inhibitory activities against human lung cancer cells (A549) and murine leukemia cells (P388) were evaluated by CCK-8 (cell counting kit-8) method. All these compounds exhibit a certain level of anti-tumor activities, while compounds H1, H4,H6 possess better cytotoxicity profile than tetrandrine against A549 cells. |
WOS研究方向 | Chemistry (provided by Clarivate Analytics) |
语种 | 中文 |
CSCD记录号 | CSCD:6024121 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/269200] |
专题 | 天然药物化学研究室 |
作者单位 | 1.Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Shanghai 201203, China. 2.School of Pharmaceutical Science, Shanxi Medical University, Taiyuan, Shanxi 030001, China.; |
推荐引用方式 GB/T 7714 | Guo Weifeng,Xu Jinfang,Liu Ruiling,et al. Synthesis of Tetrandrine Derivatives and Their Biological Activity[J]. Chinese Journal of Applied Chemistry,2017,34(7):789-794. |
APA | Guo Weifeng,Xu Jinfang,Liu Ruiling,Zhao Zhengbao,&Guo Yuewei.(2017).Synthesis of Tetrandrine Derivatives and Their Biological Activity.Chinese Journal of Applied Chemistry,34(7),789-794. |
MLA | Guo Weifeng,et al."Synthesis of Tetrandrine Derivatives and Their Biological Activity".Chinese Journal of Applied Chemistry 34.7(2017):789-794. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论